The global injectable drugs market belongs to the wide spectrum of the global pharmaceutical market, which was valued at $1.23 trillion in 2016. The global pharmaceutical market can be broadly divided into several submarkets, and injectable drugs market is one among them. The global injectable drugs market accounts for 27.98% of the global pharmaceutical market.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Market outline

ROA

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by molecule type

Biologics

Small molecules

PART 08: Geographical segmentation

Injectable drugs market in Americas

Injectable drugs market in EMEA

Injectable drugs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

Market drivers

Market challenges

PART 11: Market trends

Rising awareness leading to high demand for injectable

drugs

Increase in industry-academia collaboration

Expected entry of novel vaccines

Advent of biosimilars

PART 12: Vendor landscape

Competitive landscape

PART 13: Key vendor analysis

AbbVie

F. Hoffmann-La Roche

GlaxoSmithKline

Sanofi

Other prominent vendors

PART 14: Appendix

List of abbreviations

PART 15: Explore Technavio